1887

Journal of General Virology header logo

Volume 82, Issue 10

Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (G): induction of virus-neutralizing antibody and assessment of protection in ponies Free

Abstract

An -expressed recombinant protein (6hisGecto) comprising the entire ectodomain (aa 18–122) of equine arteritis virus (EAV) glycoprotein G, the immunodominant viral antigen, induced higher neutralizing antibody titres than other G-derived polypeptides when compared in an immunization study in ponies. The potential of the recombinant G ectodomain to act as a sub-unit vaccine against EAV was evaluated further in three groups of four ponies vaccinated with doses of 35, 70 or 140 μg of protein. All vaccinated animals developed a virus-neutralizing antibody (VNAb) response with peak titres 1–2 weeks after the administration of a booster on week 5 (VNAb titres of 1·8–3·1), 13 (VNAb titres of 1·4–2·9) or 53 (VNAb titres of 1·2–2·3). Vaccinated and unvaccinated control ponies were infected with EAV at different times post-vaccination to obtain information about the degree of protection relative to the levels of pre-challenge VNAb. Vaccination conferred varying levels of protection, as indicated by reduced or absent pyrexia, viraemia and virus excretion from the nasopharynx. The degree of protection correlated well with the levels of pre-challenge VNAb and, in particular, with levels of virus excretion. These results provide the first evidence that a sub-unit vaccine protects horses against EAV. The use of the sub-unit vaccine in combination with a differential diagnostic test based on other EAV antigens would enable serological discrimination between naturally infected and vaccinated equines.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-10-2425
2001-10-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/10/0822425a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-10-2425&mimeType=html&fmt=ahah

References

  1. Balasuriya U. B., Rossitto P. V., DeMaula C. D., MacLachlan N. J. 1993; A 29K glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. Journal of General Virology 74:2525–2529
     [Google Scholar]
  2. Balasuriya U. B. R., MacLachlan N. J., de Vries A. A. F., Rossitto P. V., Rottier P. J. M. 1995; Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Virology 207:518–527
     [Google Scholar]
  3. Balasuriya U. B. R., Patton J. F., Rossitto P. V., Timoney P. J., McCollum W. H., MacLachlan N. J. 1997; Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the GL envelope glycoprotein. Virology 232:114–128
     [Google Scholar]
  4. Balasuriya U. B., Heidner H. W., Hedges J. F., Williams J. C., Davis N. L., Johnston R. E., MacLachlan N. J. 2000; Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. Journal of Virology 74:10623–10630
     [Google Scholar]
  5. Chirnside E. D., de Vries A. A. F., Mumford J. A., Rottier P. J. M. 1995a; Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL. Journal of General Virology 76:1989–1998
     [Google Scholar]
  6. Chirnside E. D., Francis P. M., Mumford J. A. 1995b; Expression cloning and antigenic analysis of the nucleocapsid protein of equine arteritis virus. Virus Research 39:277–288
     [Google Scholar]
  7. Cochran W. G., Cox G. M. 1957 Experimental Designs London: John Wiley;
  8. den Boon J. A., Snijder E. J., Chirnside E. D., de Vries A. A. F., Horzinek M. C., Spaan W. J. M. 1991; Equine arteritis virus is not a togavirus but belongs to the coronavirus-like superfamily. Journal of Virology 65:2910–2920
     [Google Scholar]
  9. Deregt D., de Vries A. A. F., Raamsman M. J. B., Elmgren L. D., Rottier P. J. M. 1994; Monoclonal antibodies to equine arteritis virus proteins identify the GL protein as a target for virus neutralization. Journal of General Virology 75:2439–2444
     [Google Scholar]
  10. de Vries A. A., Chirnside E. D., Horzinek M. C., Rottier P. J. 1992; Structural proteins of equine arteritis virus. Journal of Virology 66:6294–6303
     [Google Scholar]
  11. de Vries A. F., Chirnside E. D., Horzinek M. C., Rottier P. J. 1993; Equine arteritis virus contains a unique set of four structural proteins. Advances in Experimental Medicine and Biology 342:245–253
     [Google Scholar]
  12. Doll E. R., Bryans J. T., Wilson J. C., McCollum W. H. 1968; Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney. Cornell Veterinarian 48:497–524
     [Google Scholar]
  13. Edwards S., Castillo-Olivares J., Cullinane A., Lable J., Lenihan J., Mumford J. A., Paton D. J., Pearson J. E., Sinclair R., Westcott D. G. F., Wood J. L. N., Zientara S., Nelly M. 1998; International harmonisation of laboratory diagnostic tests for equine viral arteritis. In Proceedings of the 8th International Conference on Equine Infectious Diseases pp 359–362 Edited by Wernery U., Wade J. F., Mumford J. A., Kaaden O.-R. Newmarket: R&W Publications;
     [Google Scholar]
  14. Fukunaga Y., Imagawa H., Tabuchi E., Akiyama Y. 1981; Clinical and virological findings on experimental equine viral arteritis in horses. Bulletin of Equine Research Institute 18:110–118
     [Google Scholar]
  15. Fukunaga Y., Wada R., Hirasawa K., Kamada M., Kumanomido T., Akiyama Y. 1982; Effect of the modified Bucyrus strain of equine arteritis virus experimentally inoculated into horses. Bulletin of Equine Research Institute 19:97–101
     [Google Scholar]
  16. Fukunaga Y., Wada R., Kamada M., Kumanomido T., Akiyama Y. 1984; Tentative preparation of an inactivated virus vaccine for equine viral arteritis. Bulletin of Equine Research Institute 21:56–64
     [Google Scholar]
  17. Fukunaga Y., Wada R., Matsumura T., Sugiura T., Imagawa H. 1990; Induction of immune response and protection from equine viral arteritis (EVA) by formalin-inactivated virus vaccine for EVA in horses. Zentralblatt fuer Veterinaermedizin Beiheft/Reihe B 37:135–141
     [Google Scholar]
  18. Fukunaga Y., Wada R., Matsumura T., Anzai T., Imagawa H., Sugiura T., Kumanomido T., Kanemaru T., Kamada M., Plowright W., Rossdale P. D., Wade J. F. 1991; An attempt to protect against persistent infection of equine viral arteritis in the reproductive tract of stallions using formalin-inactivated virus vaccine. In Equine Infectious Diseases. VI. Proceedings of the 6th International Conference pp 239–244 Edited by Plowright W., Rossdale P. D., Wade J. F. Newmarket: R&W Publications;
     [Google Scholar]
  19. Fukunaga Y., Wada R., Kanemaru T., Imagawa H., Kamada M., Samejima T., Nakajima H., Plowright W. 1994; Protection against abortion in pregnant mares vaccinated with killed vaccine after exposure to equine arteritis virus. In Equine Infectious Diseases. VII. Proceedings of the Seventh International Conference pp 340 Edited by Nakajima H., Plowright W. Newmarket: R&W Publications;
     [Google Scholar]
  20. Fukunaga Y., Wada R., Kanemaru T., Imagawa H., Kamada M., Samejima T. 1996; Immune potency of lyophilized, killed vaccine for equine viral arteritis and its protection against abortion in pregnant mares. Journal of Equine Veterinary Science 16:217–221
     [Google Scholar]
  21. Fukunaga Y., Wada R., Imagawa H., Kanemaru T. 1997; Venereal infection of mares by equine arteritis virus and use of killed vaccine against the infection. Journal of Comparative Pathology 117:201–208
     [Google Scholar]
  22. Gerber H., Steck F., Hofer B., Walther L., Friedli U. 1978; Serological investigations on equine viral arteritis. In Proceedings of the 4th International Conference on Equine Infectious Diseases pp 461–465 Edited by Bryans B. T., Gerber H. Princeton: Veterinary Publications;
     [Google Scholar]
  23. Hedges J. F., Balasuriya U. B., Ahmad S., Timoney P. J., McCollum W. H., Yilma T., MacLachlan N. J. 1998; Detection of antibodies to equine arteritis virus by enzyme linked immunosorbant assays utilizing GL, M and N proteins expressed from recombinant baculoviruses. Journal of Virological Methods 76:127–137
     [Google Scholar]
  24. Hedges J. F., Balasuriya U. B., MacLachlan N. J. 1999; The open reading frame 3 of equine arteritis virus encodes an immunogenic glycosylated, integral membrane protein. Virology 264:92–98
     [Google Scholar]
  25. Iwashita O., Harasawa R. 1987; Translation of equine arteritis virus RNA in rabbit reticulocyte lysates. Nippon Juigaku Zasshi 49:387–389
     [Google Scholar]
  26. Karber G. 1931; Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Naunyn-Schmiedebergs Archiv fuer Experimentelle Pathologie und Pharmakologie 162:480–483
     [Google Scholar]
  27. Kheyar A., Martin S., St-Laurent G., Timoney P. J., McCollum W. H., Archambault D. 1997; Expression cloning and humoral immune response to the nucleocapsid and membrane proteins of equine arteritis virus. Clinical and Diagnostic Laboratory Immunology 4:648–652
     [Google Scholar]
  28. Lopez J. W., del Piero F., Glaser A., Finazzi M. 1996; Immunoperoxidase histochemistry as a diagnostic tool for detection of equine arteritis virus antigen in formalin-fixed tissues. Equine Veterinary Journal 28:77–79
     [Google Scholar]
  29. McCollum W. H. 1969; Development of a modified virus strain and vaccine for equine viral arteritis. Journal of the American Veterinary Medical Association 155:318–322
     [Google Scholar]
  30. McCollum W. H. 1970; Vaccination for equine arteritis virus. In Proceedings of the 2nd International Conference on Equine Infectious Diseases pp 143–151 Edited by Bryans J. B., Gerber H. Basel: Karger;
     [Google Scholar]
  31. McCollum W. H. 1976; Studies of passive immunity in foals to equine viral arteritis. Veterinary Microbiology 1:45–54
     [Google Scholar]
  32. McCollum W. H. 1986; Responses of horses vaccinated with avirulent modified-live equine arteritis virus propagated in the equine dermal (NBL-6) cell line to nasal inoculation with virulent virus. American Journal of Veterinary Research 47:1931–1934
     [Google Scholar]
  33. McCollum W. H., Doll E. R., Wilson J. C., Johnson C. B. 1961; Propagation of equine arteritis virus in monolayer cultures of equine kidney. American Journal of Veterinary Research 22:731–735
     [Google Scholar]
  34. McCollum W. H., Prickett M. E., Bryans J. T. 1971; Temporal distribution of equine arteritis virus in respiratory mucosa, tissues and body fluids of horses infected by inhalation. Research in Veterinary Science 12:459–464
     [Google Scholar]
  35. McCollum W. H., Bryans J. T., Gerber H. 1973; Serological identification of infection by equine arteritis virus in horses of several countries. In Proceedings of the 3rd International Conference on Equine Infectious Diseases pp 256–263 Edited by Bryans J. T., Gerber H. Basel: S. Karger;
     [Google Scholar]
  36. McCollum W. H., Timoney P. J., Roberts A. W., Willard J. E., Carswell G. D. 1987; Response of vaccinated and non-vaccinated mares to artificial insemination with semen from stallions persistently infected with equine arteritis virus. In Proceedings of the 5th International Conference on Equine Infectious Diseases pp 13–18 Edited by Powell D. G. Lexington: Kentucky University Press;
     [Google Scholar]
  37. McCue P. M., Hietala S. K., Spensley M. S., Stillian M., Mihalyi J., Hughes J. P. 1991; Prevalence of equine viral arteritis in California horses. California Veterinarian 45:24–26
     [Google Scholar]
  38. McKinnon A. O., Colbern G. T., Collins J. K., Bowen R. A., Voss J. L., Umphenour N. W. 1986; Vaccination of stallions with modified live equine viral arteritis virus. Journal of Equine Veterinary Science 6:66–69
     [Google Scholar]
  39. MacLachlan N. J., Balasuriya U. B. R., Hedges J. F., Schweidler T. M., McCollum W. H., Timoney P. J., Hullinger P. J., Patton J. F. 1998; Serological response of horses to the structural proteins of equine arteritis virus. Journal of Veterinary Diagnostic Investigation 10:229–236
     [Google Scholar]
  40. Nugent J., Sinclair R., de Vries A. A. F., Eberhardt R. Y., Castillo-Olivares J., Davis-Poynter N., Rottier P. J. M., Mumford J. A. 2000; Development and evaluation of ELISA procedures to detect antibodies against the major envelope protein GL of equine arteritis virus. Journal of Virological Methods 90:167–183
     [Google Scholar]
  41. Paweska J. T., Aitchison H., Chirnside E. D., Barnard B. J. 1996; Transmission of the South African asinine strain of equine arteritis virus (EAV) among horses and between donkeys and horses. Onderstepoort Journal of Veterinary Research 63:189–196
     [Google Scholar]
  42. Scheffe H. 1959 The Analysis of Variance London: John Wiley;
  43. Senne D. A., Pearson J. E., Carbrey E. A. 1985; Equine viral arteritis: a standard procedure for the virus neutralization test and comparison of results of a proficiency test performed at five laboratories. Proceedings of the United States Animal Health Association 89:29–34
     [Google Scholar]
  44. Snijder E. J., Meulenberg J. J. M. 1998; The molecular biology of arteritiviruses. Journal of General Virology 79:961–979
     [Google Scholar]
  45. Snijder E. J., van Tol H., Pedersen K. W., Raamsman M. J., de Vries A. A. 1999; Identification of a novel structural protein of arteriviruses. Journal of Virology 73:6335–6345
     [Google Scholar]
  46. Stadejek T., Björklund H., Bascuñana C. R., Ciabatti I. M., Scicluna M. T., Amaddeo D., McCollum W. H., Autorino G. L., Timoney P. J., Paton D. J., Klingeborn B., Belák S. 1999; Genetic diversity of equine arteritis virus. Journal of General Virology 80:691–699
     [Google Scholar]
  47. Steel R. G. D., Torrie J. H. 1980 In Principles and Procedures of Statistics, 2nd edn. New York: McGraw–Hill;
     [Google Scholar]
  48. Timoney P. J., McCollum W. H. 1988; Equine viral arteritis: epidemiology and control. Journal of Equine Veterinary Science 8:54–59
     [Google Scholar]
  49. Timoney P. J., McCollum W. H. 1990; Equine viral arteritis: current clinical and economic significance. Proceedings of the American Association of Equine Practitioners 36:403–440
     [Google Scholar]
  50. Timoney P. J., McCollum W. H. 1993; Equine viral arteritis in perspective in relation to international trade. Journal of Equine Veterinary Science 13:50–52
     [Google Scholar]
  51. Timoney P. J., Umphenour N. W., McCollum W. H., Powell D. G. 1988; Safety evaluation of a commercial modified live equine arteritis virus vaccine for use in stallions. In Proceedings of the 5th International Conference on Equine Infectious Diseases pp 19–27 Edited by Powell D. G. Lexington: Kentucky University Press;
     [Google Scholar]
  52. Wood J. L., Chirnside E. D., Mumford J. A., Higgins A. J. 1995; First recorded outbreak of equine viral arteritis in the United Kingdom. Veterinary Record 136:381–385
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-10-2425
Loading
Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (GL): induction of virus-neutralizing antibody and assessment of protection in ponies
J. Gen. Virol. 82, 2425 (2001); https://doi.org/10.1099/0022-1317-82-10-2425
/content/journal/jgv/10.1099/0022-1317-82-10-2425
/content/journal/jgv/10.1099/0022-1317-82-10-2425
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error